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Abstract 
 
A convenient synthesis of (S)-proline hydrazide 2a via the reaction of ethyl (S)-N-
benzylprolinate with hydrazine hydrate and subsequent deprotection of (S)-N-benzyl 
proline hydrazide 5 is described. The latter, in methanolic solution, reacted with 
aromatic aldehydes as well as with cycloaliphatic ketones at room temperature to give 
the corresponding hydrazones of type 7 in good yields. The structure of the product with 
furan carbaldehyde 7b, proving the (E)-configuration of the hydrazone, was established 
by X-ray crystallography. In the case of the unprotected (S)-proline hydrazide 2a, the 
analogous reaction with aromatic aldehydes led to the expected hydrazones 7 or the 1H-
pyrrolo[1,2-c]imidazol-1-one derivatives 8, depending on the reaction conditions. The 
latter is formed via a secondary cyclocondensation of the initially formed 7 with a 
second molecule of the aldehyde. Whereas the reaction of (S)-N-benzyl proline 
hydrazide 5 with butyl isocyanate and isothiocyanate gave the corresponding 
semicarbazide and thiosemicarbazide, respectively, of type 9, the unprotected (S)-
proline hydrazide 2a yielded the 1:2 adducts 10. Thiosemicarbazide 9b underwent 
cyclization reactions under basic (NaOH) and acidic (H2SO4) conditions to yield (S)-
prolinyl-substituted 1,2,4-triazole-3-thione 11 and 1,3,4-thiadiazole-2-amine 12, 
respectively. 
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1. Introduction 
 
It is well documented that enantiopure (S)-proline 1a (R = H) and its derivatives 
belong to privileged compounds widely applied in the field of asymmetric synthesis and 
organocatalysis.2 On the other hand, carbohydrazides form an important class of 
building blocks for the preparation of diverse N-heterocycles3 with practical 
applications as agrochemicals and pharmaceuticals.4 Moreover, a variety of hydrazones 
derived from hydrazides are known for their biological activities.5 Finally, also some 
hydrazides are used as pharmaceuticals, and isoniazid (isonicotinohydrazide), 
synthesized for the first time at the beginning of the 20th century, is the best known 
example of this class of compounds.6 
Whereas proline amides and thioamides are rather well known and have been 
explored successfully as catalyst and ligands,7 the related proline hydrazides 2 are less 
known. To the best of our knowledge, hydrazides of the non-protected (S)-proline are 
described only scarcely. The syntheses of (S)-pyroline hydrazide 2a (R1 = R2 = H) by 
using anhydrous (absolute) hydrazine, as well as some of its hydrazones 3 (Scheme 1), 
were published in 1993.8a Interestingly, in another paper, the authors reported the 
formation of bicyclic 1:2 products, i.e., 2,3-disubstituted 1,3-diazabicyclo[3.3.0]octan-
4-ones.8b 
Treatment of (S)-proline with hydrazine hydrate in large excess at elevated 
temperature led to 4-amino-3,5-bis(2-pyrrolidine)-1,2,4-triazoles,9 and proline 
hydrazide 2a was proposed as key intermediate in the reaction. A biologically active 
hydrazone derived from proline hydrazide was prepared by using 2-
chloroacetophenone.10 In a very recent report, proline hydrazide prepared from methyl 
(S)-prolinate hydrochloride and excess hydrazine hydrate in methanolic solution was 
isolated and fully characterized.11 The formed hydrazine hydrochloride was removed 
from the crude product via precipitation from methanol. In a recent study, the 
preparation of N’-mono- and N’,N’-disubstituted (S)-proline hydrazides and their 
application as catalysts for asymmetric aldol reactions is reported.12 
Due to our current interest in the synthesis and applications of heterocyclic 
carbohydrazides13 as well as asymmetric synthesis,14 we report now a convenient and 
efficient protocol for the preparation of (S)-proline hydrazide 2a, which is a promising 
reagent for further, diverse applications. 
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2. Results and discussion 
 
A typical procedure for the synthesis of acid hydrazides is the treatment of the 
corresponding esters with hydrazine hydrate.15 Using this method, ethyl (S)-N-benzyl 
prolinate 4 can easily be transformed into (S)-N-benzyl proline hydrazide 5 in high yield 
(Scheme 2, see ref.16).  
 
Scheme 2 
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In our hands, the reaction of methyl (S)-prolinate 1b with a commercial aqueous 
solution of hydrazine (80%), carried out at room temperature, resulted in its hydrolysis, 
and proline 1a was isolated as the sole product. Following the protocol reported in 
ref.11, we obtained 2a contaminated with hydrazine hydrochloride, which could not be 
removed completely by repeated treatment with methanol. On the other hand, when the 
aqueous hydrazine solution was distilled over KOH pellets and then used for the 
reaction with 1b, a crystalline product was obtained, which was identified as the well 
known diketopiperazine derivative 6 (Scheme 3).12 In another experiment, the 
sequential treatment of 1a with thionyl chloride and hydrazine hydrate also led to 6. 
Most likely, in both cases, hydrazine hydrate only acted as a base.  
 
Scheme 3 
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Having in hand the N-benzylated hydrazide 5, the non-protected 2a was prepared 
by standard hydrogenolysis over palladium on charcoal. Alternatively, substrate 5 was 
converted into 2a using ammonium formate in boiling methanolic solution, in the 
presence of Pd/C as a deprotecting reagent. The physicochemical and spectroscopic 
properties of 2a fitted well with the data reported in the literature.8a,11 Thus, the method 
presented in Scheme 2 opens a convenient access to pure 2a on a multigram scale. 
In the second part of the study, selected reactions with hydrazides 2a and 5 were 
performed using aldehydes, ketones, butyl isocyanate, and butyl isothiocyanate. The N-
benzylated proline hydrazide 5 reacted smoothly with aldehydes at room temperature 
yielding the expected hydrazones 7 as a single isomer in each case (Scheme 4). The 1H-
NMR spectra showed that a single isomer is also present in solution. In the case of the 
non-protected proline hydrazide 2a, the reaction course was dependent on the applied 
protocol and a test reaction was carried out with 4-methoxybenzaldehyde. Whereas slow 
addition of the aldehyde to a stirred solution of 2a at room temperature led to the 
expected hydrazone 7e, the reversed addition of both reagents (2a was added in small 
portions to a stirred solution of excess aldehyde) resulted in exclusive formation of the 
corresponding 1:2 product of type 8 in a diastereoselective manner (Scheme 5). 
Surprisingly, in two earlier publications,8a,8b both types of products, i.e. hydrazones 7 
and 1:2 products 8, were obtained using the same protocol based on addition of the 
corresponding aldehyde in one portion to the solution of 2a at room temperature. In our 
hands, upon application of this protocol, formation of both products in a ratio of ca. 1:1 
was observed.  
It is worth mentioning that, in contrast to hydrazones 7a–d, the non-protected 
analogues 7e–i exist in solution as mixtures of two stereoisomers or conformers (1H-
NMR evidence). On the basis of the present data, it is not possible to formulate a 
convincing explanation of this phenomenon.  
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Similarly to aromatic aldehydes, reactions of 2a and 5 with less reactive 
cyclohexanone and adamantanone also occurred smoothly at room temperature in 
MeOH solutions. In all cases the expected hydrazones were obtained in high yields as 
crystalline materials.    
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N
O
H
N
R
5   (R = Bn)
2a (R = H)
7a R = Bn, R1 = H, R2 = 4-MeOC6H4
7b R = Bn, R1 = H, R2 = 2-Furyl
7c R = Bn, R1-R2 = (CH2)5
7d R = Bn, R1-R2 = Adamantyl
7e R = R1 = H, R2 = 4-MeOC6H4
7f  R = R1 = H, R2 = 4-NO2C6H4
7g  R = R1 = H, R2 = 2-Furyl
7h R = H, R1-R2 = (CH2)5
7i R = H, R1-R2 = Adamantyl
N
O
NHNH2
R R2
O
R1 N+ R2
R1
2a  + 2 ArCHO N
N
O
N
Ar
H
Ar
H
MeOH
MeOH 8a Ar = 4-MeOC6H4
8b Ar = 4-NO2C6H4
8c Ar = 2-Furyl
 
 
Hydrazone 7b was obtained as a crystalline material suitable for an X-ray crystal 
structure analysis (Figure 1). The compound in the crystal is enantiomerically pure and 
the absolute configuration of the molecule has been determined independently by the 
diffraction experiment.  The molecule has the expected S-configuration and the C=N 
bond is (E)-configured. The amide group forms an intramolecular hydrogen bond with 
the ring N-atom to give a loop with a graph set motif18 of S(5).   
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Figure 1. ORTEP plot17 of the molecular structure of 7b (arbitrary numbering of the 
atoms; 50% probability ellipsoids) 
 
Reactions of butyl isocyanate and butyl isothiocyanate with 5 occur smoothly in 
boiling ethanol yielding the desired semicarbazide 9a and thiosemicarbazide 9b, 
respectively (Scheme 5). On the other hand, treatment of the non-protected 2a with 1 
mol-equivalent of butyl isocyanate and butyl isothiocyanate, respectively, resulted in the 
formation of the 1:2 adducts 10a and 10b, i.e., the products of a two-fold addition, 
which were obtained along with unconverted starting material 2a. In another experiment 
with 2 mol-equivalents of the hetereocumulene, the conversion of 2a to the 
corresponding compounds 10 was complete. These results show that these additions 
occur non-selectively and, remarkably, no 1:1 adduct was obtained regardless of the 
applied reaction conditions. 
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It is well established that thiosemicarbazides derived from carbohydrazides are 
versatile starting materials for the preparation of diverse heterocycles.13,15 Thus, heating 
of 9b in aqueous NaOH gave the 1,2,4-triazole-3-thione 11, whereas the reaction in 
H2SO4 at room temperature yielded the 1,3,4-thiadiazol-2-amine derivative 12 (Scheme 
6). Further studies aimed at the exploration of proline hydrazides for the preparation of 
enantiomerically pure bis-heterocyclic products are in progress. 
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3. Conclusions 
 
The present study shows that non-protected (S)-proline hydrazide 2a can be 
prepared conveniently by using aqueous hydrazine and N-benzyl prolinate with 
subsequent deprotection of the N-atom. Both optically active (S)-proline derived 
hydrazides 2a and 5 react with aldehydes and cyclic ketones yielding the corresponding 
hydrazones 7. However, in the case of the reaction with aldehydes, depending on the 
reaction conditions, a secondary process leading to a product of type 8 competes with 
the formation of the corresponding hydrazone. The formation of 8 is rationalized by the 
cyclocondensation of the initially formed hydrazone 7 with a second molecule of the 
aldehyde. Furthermore, the reactions of the N-benzylated hydrazide 5 with butyl 
isocyanate and isothiocyanate afforded semicarbazides and thiosemicarbazides, 
respectively, which are attractive building blocks for the preparation of chiral bis-
heterocycles such as 1,3,4-thiadiazoles and 1,2,4-triazol-2-thiones. These compounds 
and other products derived from 2a and 5 are of interest as promising organocatalysts 
and ligands for asymmetric synthesis. Additions of butyl isocyanate and butyl 
isothiocyanate with the non-protected 2a occur at both N-atoms in a non-selective 
manner. 
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4. Experimental  
 
4.1. General 
 
 Melting points were determined in a capillary using a Melt-Temp. II apparatus 
(Aldrich) or STUART SMP30 and are uncorrected. IR Spectra were recorded on a 
NEXUS FT-IR spectrophotometer in KBr; absorptions (ν) in cm–1. 1H and 13C{1H} 
NMR spectra were measured on a Bruker Avance III instrument (600 and 150 MHz, 
resp.) using solvent signals as reference. Chemical shifts (δ) are given in ppm and 
coupling constants J in Hz. Assignments of signals in 13C NMR spectra were made on 
the basis of HMQC experiments. HR-MS: Bruker Esquire LC spectrometers. Optical 
rotations were determined on a PERKIN-ELMER 241 MC polarimeter for λ = 589 nm. 
 
4.2. Starting Materials  
 All solvents and reagents are commercially available and were used as received. 
Ethyl (S)-N-benzylprolinate 4 and methyl (S)-prolinate 1b were prepared following a 
known protocol based on the treatment of the corresponding amino acid, dissolved in 
ethanol or methanol, with thionyl chloride.11  
 
4.3. Synthesis of (S)-proline hydrazide 2a 
 
 Procedure A: To a magnetically stirred solution of (S)-N-benzylproline 
hydrazide 5 (10 mmol) in MeOH (5 ml) was added 10% Pd/C (300 mg). Then, H2 gas 
was bubbled through the solution for 24 h; the progress of the reaction was followed by 
TLC (SiO2, MeOH/CH2Cl2 1:4). After the starting hydrazide was consumed, Pd/C was 
filtered and the resulting solution was concentrated under reduced pressure. The 
obtained highly pure product 2a was analyzed without further purification. Yield: 1.161 
g (90%).  
 Procedure B: To a magnetically stirred solution of (S)-N-benzylproline 
hydrazide 5 (5 mmol) in MeOH (10 ml) was added 10% Pd/C (165 mg) and HCOONH4 
(5 eq). The mixture was heated to reflux for 1 h. After cooling to r.t., Pd/C was filtered 
and the resulting solution was concentrated under reduced pressure. The obtained highly 
pure product 2a was analyzed without further purification. Yield: 0.121 g (94%). IR 
(film): ν 3328s (HN), 2976m, 1659vs (C=O), 1541m, 1410m. 1H NMR (CDCl3): δ 8.50 
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(br. s, HN); 3.74–3.71 (m, CH); 2.95–2.80 (m, 2H); 2.61 (br. s, NH2); 2.10–2.03 (m, 
1H); 1.87–1.82 (m, 1H); 1.70–1.60 (m, 2H). 13C NMR (CDCl3) ): δ 175.1 (C=O); 59.9 
(CH); 47.2, 30.6, 26.1 (3 CH2). HR-ESI-MS: 130.0974 (calcd 130.0975 for C5H12N3O, 
[M+1]+). [α]D25 = –38 (c 1.00, MeOH).  
 
4.4. Synthesis of (S)-N-benzylproline hydrazide 5 
 
 To a solution of freshly prepared (S)-N-benzylproline ethyl ester 4 (10 mmol) in 
MeOH (5 ml) was added NH2NH2·H2O (20 mmol). The mixture was stirred for 16 h at 
r.t., and the solvent was evaporated under vacuum. The obtained highly pure product 5 
was analyzed without further purification. Yield: 2.102 g (96%). Pale yellow oil. IR 
(film): ν 3316s (HN), 2969s, 1663vs (C=O), 1496s, 701m. 1H NMR (CDCl3): δ 8.26 (s, 
HN); 7.32–7.23 (m, 5 arom. H); 3.81, 3.51 (AB, JAB = 13.2, CH2Ph); 3.28–3.26 (m, 
CH); 3.02–2.99 (m, 1H); 2.36–2.32 (m, 1H); 2.22–2.18 (m, 1H); 1.89–1.68 (m, 3H). 13C 
NMR (CDCl3): δ 174.7 (C=O); 138.4 (1 arom. C); 128.7, 128.5, 127.3 (5 arom. CH); 
66.5 (CH); 60.0 (CH2Ph); 54.0, 30.6, 24.1 (3 CH2). HR-ESI-MS: 220.1443 (calcd 
220.1444 for C12H18N3O, [M+1]+). [α]D25 = – 70 (c 1.00, MeOH). 
 
4.5. Synthesis of diketopiperazine 6 
 
 Procedure A: To a solution of freshly prepared (S)-proline methyl ester 1b (10 
mmol) in MeOH (5 ml), was added NH2NH2·H2O (20 mmol) distilled over KOH 
pellets. The mixture was stirred for 16 h at r.t., and the solvent was evaporated under 
vacuum to give 6. Yield: 1.223 g (63%). Colorless crystals. Mp 140–142 °C; lit.12b, mp 
144–145 °C. 
 Procedure B: A mixture of (S)-proline 1a (10 mmol) and thionyl chloride (2.4 
ml) was heated to reflux for 30 min. After cooling to r.t., an excess of NH2NH2·H2O 
(1.18 ml) distilled over KOH pellets was added and the mixture heated to reflux for 1 h. 
Then, water was added and the aqueous layer was extracted with CHCl3, the organic 
layer was dried over Na2SO4, and the solvent was evaporated. The residue was passed 
through a silica gel plug to give 6. Yield: 0.524 g (27%). Colorless crystals. Mp 139–
141 °C. 
 
4.6. General procedure for the synthesis of hydrazones 7a–d 
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 To a stirred solution of a hydrazide 5 (1 mmol) in MeOH (5 ml) at 20 °C, an 
equimolar quantity of the carbonyl component was added slowly. The mixture was 
stirred for 16 h at r.t., the solution was concentrated, the resulting solid was treated with 
Et2O, filtered, and crystallized from an appropriate solvent.  
 
4.6.1. (2S)-1-Benzyl-N-[(E)-(4-methoxyphenyl)methylidene]pyrrolidine-2-
carbohydrazide 7a 
 Yield: 0.250 g (74%). Colorless crystals. Mp 94–96 °C (EtOH). IR (KBr): ν 
3255s (HN), 2973m, 1676vs (C=O), 1603s, 1506m, 1255m. 1H NMR (CDCl3): δ 10.21 
(br. s, HN); 7.99 (s, HC=N); 7.71, 6.93 (AA’BB’, JAB = 8.3, 4 arom. H); 7.39–7.28 (m, 
5 arom. H); 3.93, 3.65 (AB, JAB = 13.2, CH2Ph); 3.86 (s, MeO); 3.45–3.42 (m, CH); 
3.16–3.14 (m, 1H); 2.52–2.47 (m, 1H); 2.35–2.31 (m, 1H); 2.10–1.77 (m, 3H). 13C 
NMR (CDCl3): δ 170.4 (C=O); 148.1 (C=N); 138.4, 130.1, 126.3 (3 arom C); 129.3, 
128.7, 128.6, 127.5, 114.1 (9 arom. CH); 67.1 (CH); 60.1 (CH2Ph); 55.4 (MeO); 54.3, 
30.8, 24.3 (3 CH2). HR-ESI-MS: 338.1865 (calcd 338.1863 for C20H24N3O2, [M+1]+). 
[α]D
25 = +104 (c 1.00, MeOH).  
 
4.6.2. (2S)-1-Benzyl-N-[(E)-2-furylmethylidene]pyrrolidine-2-carbohydrazide 7b 
 Yield: 0.232 g (69%). Colorless crystals. Mp 135–136 °C (EtOH). IR (KBr): ν 
3250s (HN), 2977m, 1679vs (C=O), 1515m, 1470m, 1346m. 1H NMR (CDCl3): δ 10.22 
(br. s, HN); 8.30 (s, HC=N); 7.50, 6.80, 6.47 (3d, J = 3.6, 3 furyl H); 7.35–7.25 (m, 5 
arom. H); 3.89, 3.61 (AB, JAB = 13.2, CH2Ph);  3.40–3.37 (m, CH); 3.11–3.08 (m, 1H); 
2.47–2.43 (m, 1H); 2.30–2.27 (m, 1H); 2.04–1.76 (m, 3H). 13C NMR (CDCl3): δ 170.8 
(C=O); 149.4, 138.2 (2 arom. C); 138.8 (C=N); 144.6, 128.7, 128.6, 127.6, 113.1, 111.9 
(8 arom. CH); 67.1 (CH); 60.1 (CH2Ph); 54.2, 30.8, 24.3 (3 CH2). HR-ESI-MS: 
298.1550 (calcd 298.1550 for C17H20N3O2, [M+1]+). [α]D25 = +121 (c 1.00, MeOH).  
 
4.6.3. (2S)-1-Benzyl-N-(cyclohexylidene)pyrrolidine-2-carbohydrazide 7c 
 Yield: 0.269 g (81%). Colorless crystals. Mp 85–87 °C (EtOH). IR (KBr): ν 
3198s (HN), 2933s, 1678vs (C=O), 1550m, 1209m, 741m. 1H NMR (CDCl3): δ 10.15 
(br. s, HN); 7.33–7.27 (m, 5 arom. H); 3.91, 3.56 (AB, JAB = 13.2, CH2Ph);  3.41–3.39 
(m, CH); 3.12–3.09 (m, 1 proline H); 2.44–1.62 (m, 5 proline H, 10 cyclohexyl H). 13C 
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NMR (CDCl3): δ 170.2 (C=O); 161.0 (C=N); 138.6 (1 arom C); 128.7, 128.6, 127.4 (5 
arom. CH); 67.4 (CH); 60.2 (CH2Ph); 54.3, 35.5, 30.8, 25.8, 26.7, 25.9, 25.6, 24.3 (3 
proline CH2, 5 cyclohexyl CH2). HR-ESI-MS: 300.2070 (calcd 300.2070 for 
C18H26N3O, [M+1]+).). [α]D25 = –102 (c 1.00, MeOH).  
 
4.6.4. (2S)-N-(2-Adamantylidene)-1-benzylpyrrolidine-2-carbohydrazide 7d 
 Yield: 0.263 g (75%). Colorless crystals. Mp 169–171 °C (EtOH). IR (KBr): ν 
3203s (HN), 2912s, 1666vs (C=O), 1553m, 1210m, 741m. 1H NMR (CDCl3): δ 10.17 
(br. s, HN); 7.33–7.24 (m, 5 arom. H); 3.92, 3.53 (AB, JAB = 13.2, CH2Ph); 3.42–3.39 
(m, CH); 3.10–3.08 (m, 1 proline H); 2.92, 2.82 (2 br. s, 2 adamantyl CH); 2.42–2.28 
(m, 2 proline H); 2.05–1.73 (m, 3 proline H, 12 adamantyl H). 13C NMR (CDCl3): δ 
170.3 (C=O); 167.4 (C=N); 138.7 (1 arom. C); 128.6, 128.4, 127.4 (5 arom. CH); 67.5 
(CH); 60.2 (CH2Ph); 54.3, 39.5, 39.0, 37.8, 36.3, 31.5, 30.7, 27.8, 24.4 (3 proline CH2, 9 
adamantyl C). HR-ESI-MS: 352.2382 (calcd 352.2383 for C22H30N3O, [M+1]+). [α]D25 
= –74 (c 1.00, CHCl3).  
 
4.7. General procedure for the synthesis of hydrazones 7e–i 
 
 To a stirred solution of a hydrazide 5 (1 mmol) in MeOH (5 ml) at 20 °C, an 
equimolar quantity of the carbonyl component in MeOH (10 ml) was added during 4 h. 
The mixture was stirred for 16 h at r.t., the solution was concentrated, the resulting solid 
was treated with Et2O and filtered.  
 
4.7.1. (2S)-N-[(E)-(4-Methoxyphenyl)methylidene]pyrrolidine-2-carbohydrazide 7e 
 Yield: 0.188 g (76%). Colorless crystals. Mp 85–86 °C (Et2O). IR (KBr): ν 
3257s (HN), 2965m, 1686vs (C=O), 1607s, 1513m, 1253s. 1H NMR (CDCl3): major 
isomer: δ 8.12 (s, HC=N); 7.35, 6.70 (AA’BB’, JAB = 8.3, 4 arom. H); 4.93–4.91 (m, 
CH); 3.76 (s, MeO); 3.70–3.61 (m, 2 proline H); 2.49–2.08 (m, 4 proline H); minor 
isomer: δ 8.18 (s, HC=N); 7.67 6.88 (AA’BB’, JAB = 8.3, 4 arom. H); 4.17–4.13 (m, 
CH); 3.82 (s, MeO); 3.20–3.06 (m, 2 proline H); 2.39–1.80 (m, 4 proline H). 13C NMR 
(CDCl3): major isomer: δ 161.3 (C=O); 146.7 (C=N); 142.4, 126.2, (2 arom. C); 129.3 
114.0 (4 arom. CH); 58.6 (CH); 55.2 (MeO); 46.6, 30.7, 24.6 (3 CH2); minor isomer: δ 
161.7 (C=O); 148.9 (C=N); 142.4, 126.2 (2 arom. C); 128.8, 114.1 (4 arom. CH); 59.9 
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(CH); 55.3 (MeO); 46.6, 29.8, 24.6 (3 CH2). HR-ESI-MS: 248.1392 (calcd 248.1394 for 
C13H18N3O2, [M+1]+). [α]D25 = –65 (c 1.00, MeOH).  
 
4.7.2. (2S)-N-[(E)-(4-Nitrophenyl)methylidene]pyrrolidine-2-carbohydrazide 7f 
 Yield: 0.233 g (89%). Yellow solid. Mp 264–268 °C (Et2O). IR (KBr): ν 3074m, 
2965m, 1694vs (C=O), 1518m, 1342s. 1H NMR ((D6)DMSO): major isomer: δ 8.21 (s, 
HC=N); 8.28, 8.00 (AA’BB’, JAB = 8.6, 4 arom. H); 4.86–4.83 (m, CH); 3.37–3.17 (m, 
2 proline H); 2.55–1.91 (m, 4 proline H); minor isomer: δ 8.44 (s, HC=N); 8.30, 7.97 
(AA’BB’, JAB = 8.6, 4 arom. H); 4.21–4.19 (m, CH); 3.17–3.07 (m, 2 proline H); 2.34–
1.91 (m, 4 proline H). 13C NMR ((D6)DMSO): major isomer: δ 170.7, (C=O); 143.7 
(C=N); 148.5, 140.4 (2 arom. C); 128.6, 124.5 (4 arom. CH); 58.4 (CH); 46.2, 29.3, 
24.1 (3 CH2); minor isomer: δ 166.4 (C=O); 146.5 (C=N); 148.5, 140.6 (2 arom. C); 
128.6, 124.4 (4 arom. CH); 59.0 (CH); 46.1, 30.0, 24.3 (3 CH2). HR-ESI-MS: 263.1137 
(calcd 263.1139 for C12H15N4O3, [M+1]+). [α]D25 = – 57 (c 1.00, MeOH).  
 
4.7.3. (2S)-N-[(E)-2-Furylmethylidene]pyrrolidine-2-carbohydrazide 7g 
 Yield: 0.164 g (79%). Colorless crystals. Mp 79–81 °C (Et2O). IR (KBr): ν 
3112s (HN), 2977m, 1690vs (C=O), 1625m, 1231m. 1H NMR (CDCl3): major isomer: δ 
8.13 (s, HC=N); 7.34, 6.54, 6.33 (3d, J = 3.7, 3 furyl H); 4.92–4.89, (m, CH); 3.70–3.46 
(m, 2 proline H); 2.25–2.09 (m, 4 proline H); minor isomer: δ 8.31 (s, HC=N); 7.48, 
6.68, 6.42 (3d, J = 3.7, 3 furyl H); 4.62–4.59 (m, CH); 3.57–3.36 (m, 2 proline H); 
2.55–1.90 (m, 4 proline H). 13C NMR (CDCl3): major isomer: δ 170.3 (C=O); 148.9 (1 
arom. C); 144.4, 113.9, 111.7 (3 furyl CH); 136.5 (C=N); 58.8 (CH); 46.4, 29.5, 24.4 (3 
CH2); minor isomer: δ 170.3 (C=O); 149.0 (1 arom. C); 144.8, 113.9, 112.0 (3 furyl 
CH); 139.3 (C=N); 59.5 (CH); 46.8, 30.4, 24.7 (3 CH2). HR-ESI-MS: 208.1077 (calcd 
208.1081 for C10H14N3O2, [M+1]+). [α]D25 = –80 (c 1.00, MeOH).  
 
4.7.4. (2S)-N-(Cyclohexylidene)pyrrolidine-2-carbohydrazide 7h 
 Yield: 0.082 g (39%). IR (film): ν 3261s (HN), 2935s, 1683vs (C=O), 1534m, 
1221m, 1043m. 1H NMR ((D6)DMSO): major isomer: δ 10.96 (br. s, HN); 4.09–4.06 
(m, CH); 3.27–3.17 (m, 2 proline H); 2.46–1.53 (m, 5 proline H, 10 cyclohexyl H); 
minor isomer: δ 11.10 (br. s, HN); 4.65–4.62 (m, CH); 3.27–3.17 (m, 2 proline H); 
2.46–1.53 (m, 5 proline H, 10 cyclohexyl H). 13C NMR ((D6)DMSO): major isomer: δ 
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170.5, 167.7 (C=O, C=N); 58.2 (CH); 45.8, 35.4, 30.0, 29.2, 27.3, 26.1, 25.4, 24.0 (3 
proline CH2, 5 cyclohexyl CH2); minor isomer: δ 170.5, 165.4 (C=O, C=N); 58.5 (CH); 
46.0, 35.6, 30.4, 29.3, 27.4, 26.2, 25.5, 24.1 (3 proline CH2, 5 cyclohexyl CH2). HR-
ESI-MS: 210.1598 (calcd 210.1601 for C11H20N3O, [M+1]+). [α]D25 = – 88 (c 1.00, 
MeOH).  
 
4.7.5. (2S)-N-(2-Adamantylidene)pyrrolidine-2-carbohydrazide 7i 
 Yield: 0.104 g (40%). Colorless crystals. Mp 95–97 °C (Et2O). IR (KBr): ν 
3127s (HN), 2915s, 1686vs (C=O), 1542m, 1450m, 1226m. 1H NMR ((D6)DMSO): 
major isomer:  δ 11.03 (br. s, HN); 4.31–4.28 (m, CH); 3.25–3.13 (m, 2 proline H); 
2.55, 2.49 (2 br. s, 2 adamantyl CH); 2.00–1.65 (m, 4 proline H, 12 adamantyl H);  
minor isomer: δ 10.94 (br. s, HN); 4.65–4.62 (m, CH); 2.55, 2.49 (2 br. s, 2 adamantyl 
CH); 2.41–2.25 (m, 2 proline H); 2.00–1.65 (m, 4 proline H, 12 adamantyl H). 13C 
NMR ((D6)DMSO): major isomer: δ 169.9, 166.1 (C=O, C=N); 58.7 (CH); 46.2, 39.2, 
39.0, 37.8, 36.2, 31.9, 29.4, 27.6, 24.4 (3 proline CH2, 5 adamantyl CH2 and 4 
adamantyl CH); minor isomer: δ 170.6, 166.2 (C=O, C=N); 58.4 (CH); 46.0, 39.0, 38.8, 
37.6, 36.1, 31.2, 29.3, 27.5, 24.3 (3 proline CH2, 5 adamantyl CH2, 4 adamantyl CH). 
HR-ESI-MS: 262.1912 (calcd 262.1914 for C15H24N3O, [M+1]+). [α]D25 = – 63 (c 1.00, 
MeOH).  
 
4.8. General procedure for the synthesis of compounds 8 
 
To a stirred solution of an aldehyde (2 mmol) in EtOH (5 mL), a solution of 2a 
(1 mmol) in EtOH (5 mL) was added dropwise at room temperature. The mixture was 
stirred overnight, and then the solvent was removed under reducer pressure. Crude 
product 8 was purified by crystallization or flash chromatography. 
 
4.8.1. (7aS)-3-(4-Methoxyphenyl)-2-{[(Z)-(4-methoxyphenyl)methyliden]amino} 
hexahydro-1H-pyrrolo[1,2-c]imidazol-1-one 8a 
Yield: 0.186 g (72%). Colorless oil (flash chromatography, hexane/AcOEt, 1:1) 
(lit.8a, mp 110–112 °C). IR (KBr): ν 3436br, 2963m, 2936m, 1713vs (C=O), 1608s, 
1514s, 1251s. 1H NMR (CDCl3): δ 8.32 (s, 1H, CH=N); 7.61, 6.88 (AA’BB’, JAB = 
8.82, 4 arom. H); 7.30, 6.93 (AA’BB’, JAB = 8.67, 4 arom. H); 5.55 (s, 1H, HC(6)); 
4.04–4.00 (m, 1H, HC(5)); 3.46–3.40 (m, 1H, HC(2)); 2.90–2.85 (m, 1H, HC(2)); 2.24–
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2.16 (m, 2H, HC(4)); 1.95–1.86 (m, 2H, HC(3)). 13C NMR (CDCl3): δ 172.1 (C=O); 
161.8, 160.1, 132.2, 127.1 (4 arom. C); 149.9 (C=N); 129.4, 127.7, 114.7, 114.2 (8 
arom. CH); 82.4 (C(6)); 63.3 (CH); 55.5 (2 MeO); 56.3, 27.7, 25.1 (3 proline CH2). HR-
ESI-MS: 366.1810 (calcd 366.1812 for C21H24N3O3, [M+1]+). [α]D25 = – 75 (c 1.00, 
CH2Cl2). 
 
4.8.2. (7aS)-3-(4-Nitrophenyl)-2-{[(Z)-(4-nitrophenyl)methyliden]amino} 
hexahydro-1H-pyrrolo[1,2-c]imidazol-1-one 8b 
Yield: 0.216 g (79%). Pale yellow crystals. Mp 144–145°C (Et2O). IR (KBr): ν 
3421br, 2954w, 2877w, 1714vs (C=O), 1522s, 1344s. 1H NMR (CDCl3): δ 9.27 (s, 1H, 
CH=N); 8.26, 7.77 (AA’BB’, JAB = 9.00, 4 arom. H); 8.21, 7.62 (AA’BB’, JAB = 9.00, 4 
arom. H); 5.63 (s, 1H, HC(6)); 4.04–4.00 (m, 1H, HC(5)); 3.46–3.41 (m, 1H, HC(2)); 
2.98–2.92 (m, 1H, HC(2)); 2.31–2.23 (m, 1H, HC(4)); 2.21–2.15 (m, 1H, HC(4)); 1.98–
1.89 (m, 2H, HC(3)). 13C NMR (CDCl3): δ 172.3 (C=O); 149.5 (C=N); 149.1, 148.4, 
146.2, 140.4 (4 arom. C); 128.2, 128.0, 124.3, 124.2 (8 arom. CH); 83.24 (C(6)); 63.99 
(CH); 56.40, 28.29, 25.21 (3 proline CH2). HR-ESI-MS: 396.1299 (calcd 396.1303 for 
C19H18N5O5, [M+1]+). [α]D25 = – 51 (c 1.00, CH2Cl2). 
 
4.8.3. (7aS)-3-(Furan-2-yl)-2-{[(Z)-furan-2-ylmethyliden]amino}hexahydro-1H-
pyrrolo[1,2-c]imidazol-1-one 8c 
Yield: 0.151 g (69%). Colorless crystals. Mp 184–186°C (Et2O); lit.8b, mp 183–185 °C. 
IR (KBr): ν 3436br, 3112w, 2973w, 2880w, 1700vs (C=O), 1403m, 1382m, 1335m. 1H 
NMR (CDCl3): δ 8.85 (s, 1H, CH=N), 7.53–7.48 (m, 1 furyl H); 7.43–7.39 (m, 1 furyl 
H); 6.78–6.74 (m, 1 furyl H); 6.47–6.43 (m, 1 furyl H); 6.39–6.32 (m, 2 furyl H); 5.61 
(s, 1H, HC(6)); 4.12–4.07 (m, 1H, HC(5)); 3.45–3.40 (m, 1H, HC(2)); 2.85–2.79 (m, 
1H, HC(2)); 2.25–2.12 (m, 2H, HC(4)); 1.92–1.86 (m, 2H, HC(3)). 13C NMR (CDCl3): 
δ 172.1 (C=O); 151.4, 149.7 (2 furyl C); 145.1, 143.4 (2 furyl CH); 140.8 (C=N); 114.6, 
112.2, 110.6, 108.4 (4 furyl CH); 77.3 (C(6)); 64.1 (CH); 55.76, 27.57, 25.09 (3 proline 
CH2). HR-ESI-MS: 286.1186 (calcd 286.1186 for C15H16N3O3, [M+1]+). [α]D25 = –193 
(c 0.44, CH2Cl2). 
 
4.9. General procedure for the synthesis of compounds 9a–b 
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 A mixture of 5 (1 mmol) and butyl isocyanate or isothiocyanate (1.1 mmol) in 
EtOH (5 ml) was heated to reflux for 2 h. The formed product was then filtered off and 
washed with Et2O.  
 
4.9.1. 1-{[(2S)-1-Benzylpyrrolidine-2-carbonyl]amino}-3-methylurea 9a 
 Yield: 0.312 g (98%). Colorless crystals. Mp 85–88 °C (MeOH). IR (KBr): ν 
3390s, 3277s (HN), 2958s, 1686vs (C=O), 1671vs (C=O), 1565s, 1254m, 704m. 1H-
NMR (CDCl3): δ 9.04 (br. s, HN); 7.34–7.25 (m, 5 arom. H); 5.29 (br. s, HN); 3.90, 
3.58 (AB, JAB = 13.2, CH2Ph); 3.34–3.31 (m, CH); 3.19–3.15 (m, butyl CH2); 3.08–3.06 
(m, 1 proline H); 2.42–2.40 (m, 1 proline H); 2.22–2.20 (m, 1 proline H); 1.97–1.78 (m, 
3 proline H); 1.45–1.41, 1.33–1.30 (2m, 2 butyl CH2); 0.90 (t, J = 7.8, butyl Me). 13C 
NMR (CDCl3): δ 173.5, 157.6 (2 C=O); 138.2 (1 arom. C); 129.0, 128.6, 127.5 (5 arom. 
CH); 66.4 (CH); 60.1 (CH2Ph); 54.2, 30.6, 24.2 (3 proline CH2); 39.9, 32.1, 19.9 (3 
butyl CH2); 13.7 (butyl Me). HR-ESI-MS: 319.2131 (calcd 319.2129 for C17H27N4O2, 
[M+1]+). [α]D25 = –18 (c 1.00, CHCl3).  
 
4.9.2. 1-{[(2S)-1-Benzylpyrrolidine-2-carbonyl]amino}-3-methylthiourea 9b 
 Yield: 0.272 g (93%). Pale yellow oil. IR (film): ν 3307br. s (HN), 2930s, 
1683vs (C=O), 1540s, 1455m, 1273m. 1H NMR (CDCl3): δ 9.41 (br. s, HN); 7.44–7.25 
(m, 5 arom. H); 7.01 (br. s, HN); 3.98, 3.59 (AB, JAB = 13.2, CH2Ph); 3.56–3.53 (m, 
butyl CH2); 3.35–3.32 (m, CH); 3.11–3.09 (m, 1 proline H); 2.44–2.41 (m, 1 proline H); 
2.23–2.20 (m, 1 proline H); 2.00–1.80 (m, 3 proline H); 1.58–1.53, 1.41–1.23 (2m, 2 
butyl CH2); 0.94 (t, J = 7.8, butyl Me). 13C NMR (CDCl3): δ 180.3 (C=S); 170.6 (C=O); 
137.9 (1 arom. C); 129.2, 128.5, 127.5 (5 arom. CH); 66.2 (CH); 60.3 (CH2Ph); 54.1, 
30.7, 24.2 (3 proline CH2); 44.6, 31.1, 20.1 (3 butyl CH2); 13.8 (butyl Me). HR-ESI-
MS: 335.1899 (calcd 335.1900 for C17H27N4OS, [M+1]+). [α]D25 = – 68 (c 1.00, CHCl3).  
 
4.10. General procedure for the synthesis of compounds 10a–b 
 
 A mixture of 2a (1 mmol) and butyl isocyanate or isothiocyanate (2.1 mmol) in 
EtOH (5 ml) was heated to reflux for 2 h. The formed product was then filtered off, 
washed with Et2O, and crystallized from H2O.  
 
4.10.1. 1-Butyl-3-{[(2S)-1-(butylcarbamoyl)pyrrolidine-2-carbonyl]amino}urea 10a 
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 Yield: 0.173 g (76%). Colorless crystals. Mp 80–82 °C (H2O). IR (KBr): ν 
3297s (HN), 2958s, 1674vs (C=O), 1550s, 1364m. 1H NMR ((D6)DMSO): δ 9.64 (br. s, 
HN); 7.62, 6.62, 6.28 (3s, 3 HN); 4.05–4.03 (m, CH); 3.34–3.24 (m, proline CH2); 
3.04–2.95 (m, 2 butyl CH2); 2.01–1.74 (m, 2 proline CH2); 1.41–1.36, 1.29–1.24 (2m, 4 
butyl CH2); 0.88–0.84 (m, 2 butyl Me). 13C NMR ((D6)DMSO): δ 173.4, 158.8, 157.2 (3 
C=O); 59.2 (CH); 46.3, 29.6, 25.0 (3 proline CH2); 40.6, 40.1, 32.6, 32.1, 20.1, 20.0 (6 
butyl CH2); 14.2, 14.1 (2 butyl Me). HR-ESI-MS: 350.2162 (calcd 350.2163 for 
C15H29N5NaO3, [M+Na]+). [α]D25 = – 11 (c 1.00, MeOH). 
 
4.10.2. 1-Butyl-3-{[(2S)-1-(butylthiocarbamoyl)pyrrolidine-2-carbonyl]amino} 
thiourea 10b 
 Yield: 0.289 g (78%). Colorless crystals. Mp 178–182 °C (H2O). IR (KBr): ν 
3254s (HN), 2956s, 1676vs (C=O), 1546s, 1377m, 1189m. 1H NMR ((D6)DMSO): δ 
9.97 (br. s, HN); 9.18, 7.70, 7.53 (3s, 3 HN); 4.66–4.64 (m, CH); 3.60–3.34 (m, proline 
CH2, 2 butyl CH2); 2.15–1.80 (m, 2 proline CH2); 1.55–1.46, 1.32–1.25 (2m, 4 butyl 
CH2); 0.90–0.85 (m, 2 butyl Me). 13C NMR ((D6)DMSO): δ 178.9, 173.8, 171.7 (2 C=S, 
C=O); 64.2 (CH); 48.6, 29.6, 24.5 (3 proline CH2); 45.2, 43.8, 31.5, 31.2, 20.0, 19.9 (6 
butyl CH2); 14.3, 14.2 (2 butyl Me). HR-ESI-MS: 382.1701 (calcd 382.1706 for 
C15H29N5NaOS2, [M+Na]+). [α]D25 = – 54 (c 1.00, MeOH). 
 
4.11. Synthesis of 1,2,4-triazole-3-thione 11  
 
 A mixture of 9b (1 mmol) and a 2% aqueous solution of NaOH (5 ml) was 
heated to reflux for 2 h. Then, the mixture was neutralized with AcOH, and the formed 
precipitate was filtered off and crystallized from MeOH. Yield: 0.225 g (67%). 
Colorless crystals. Mp 135–136 °C (MeOH). IR (KBr): ν 3258br. m (HN), 2964s, 
2533br. m, 1569s, 1455m, 1359m, 1297m. 1H NMR (CDCl3): δ 10.31 (br. s, HN); 7.30–
7.21 (m, 5 arom. H); 4.23–3.81 (m, butyl CH2); 3.81, 3.43 (AB, JAB = 13.2, CH2Ph); 
3.80–3.72 (m, CH); 3.44–3.13 (m, proline CH2); 2.41–1.85 (m, 2 proline CH2); 1.72–
1.32 (m, 2 butyl CH2); 0.96 (t, J = 7.8, butyl Me). 13C NMR (CDCl3): δ 161.2 (C=S); 
142.6, 137.8 (triazole C(3), arom. C); 128.8, 128.3, 127.6 (5 arom. CH); 60.1 (CH); 
58.2 (CH2Ph); 53.2, 30.2, 23.0 (3 proline CH2); 44.4, 33.2, 20.3 (3 butyl CH2); 13.6 
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(butyl Me). HR-ESI-MS: 317.1794 (calcd 317.1794 for C17H25N4S, [M+1]+). [α]D25 = –
126 (c 1.00, CHCl3). 
 
4.12. Synthesis of 1,3,4-thiadiazol-2-amine (12) 
 
 A solution of 9b (1 mmol) in 5 ml conc. H2SO4 was kept at r.t. for 1 d. After 
neutralization of the mixture with aqueous NH4OH, the solid product was filtered off, 
dried, and crystallized from MeOH. Yield: 0.177 g (56%). Yellowish crystals. Mp 99–
100 °C (MeOH). IR (KBr): ν 3242s (HN), 2953s, 1537s, 1478m, 737m. 1H NMR 
(CDCl3): δ 7.33–7.24 (m, 5 arom. H); 5.27 (br. s, HN); 4.02, 3.95 (AB, JAB = 13.2, 
CH2Ph); 3.98–3.96 (m, CH); 3.34–3.31 (m, butyl CH2); 3.07–3.04 (m, 1 proline H); 
2.36–2.31 (m, 2 proline H); 1.92–1.81 (m, 3 proline H); 1.68–1.63, 1.46–1.43 (2m, 2 
butyl CH2); 0.96 (t, J = 7.8, butyl Me). 13C NMR (CDC13): δ 170.8, 144.9 (thiadiazol 
C(2), C(5)); 139.2 (1 arom. C); 128.8, 128.3, 127.2 (5 arom. CH); 63.7 (CH); 58.0 
(CH2Ph); 53.0, 33.3, 22.9 (3 proline CH2); 47.0, 31.5, 20.0 (3 butyl CH2); 13.7 (butyl 
Me). HR-ESI-MS: 317.1794 (calcd 317.1794 for C17H25N4S, [M+1]+). [α]D25 = – 92 (c 
1.00, CHCl3). 
 
4.13. X-Ray crystal-structure determination of 7b  
 
All measurements were made on an Agilent Technologies SuperNova area-
detector diffractometer19 using CuKα radiation (λ = 1.54184 Å) from a micro-focus X-
ray source and an Oxford Instruments Cryojet XL cooler.  The data collection and 
refinement parameters are given below20 and a view of the molecule is shown in Figure 
1. Data reduction was performed with CrysAlisPro.19  The intensities were corrected for 
Lorentz and polarization effects, and an empirical absorption correction using spherical 
harmonics19 was applied. Equivalent reflections, other than Friedel pairs, were merged. 
The structure was solved by direct methods using SHELXS97,21 which revealed the 
positions of all non-hydrogen atoms. The non-hydrogen atoms were refined 
anisotropically. The amine H-atom was placed in the position indicated by a difference 
electron density map and its position was allowed to refine together with an isotropic 
displacement parameter. All remaining H-atoms were placed in geometrically calculated 
positions and refined by using a riding model where each H-atom was assigned a fixed 
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isotropic displacement parameter with a value equal to 1.2Ueq of its parent C-atom.  
The refinement of the structure was carried out on F2 by using full-matrix least-squares 
procedures, which minimised the function Σw(Fo2 – Fc2)2. A correction for secondary 
extinction was not applied. Refinement of the absolute structure parameter22 yielded a 
value of –0.0(2), while the Hooft analysis23 gave y = 0.07(5), P2 = 1.000 and P3 = 
0.000, which confidently confirms that the refined coordinates represent the true 
enantiomorph. Neutral atom scattering factors for non-H-atoms were taken from ref.24, 
and the scattering factors for H-atoms were taken from ref.25 Anomalous dispersion 
effects were included in Fc;26 the values for f' and f" were those of ref.27 The values of 
the mass attenuation coefficients are those of ref.28 All calculations were performed 
using the SHELXL9721 program. 
 
Crystal data for 7b: C17H19N3O2, M = 297.36, crystallised from isopropanol, 
colourless, prism, crystal dimensions 0.15 × 0.22 × 0.25 mm, monoclinic, space group 
P21, Z = 2, reflections for cell determination 6644, 2θ range for cell determination 6 – 
153°, a = 5.54324(6) Å, b = 10.11476(12) Å, c = 14.24604(17) Å, β = 97.5394(11), V = 
791.849(16) Å3, T = 160(1) K, DX = 1.247 g⋅cm–3, µ(CuKα) = 0.675 mm–1, scan type ω, 
2θ(max) = 153.5°, transmission factors (min; max) = 0.887; 1.000, total reflections 
measured 8322, symmetry independent reflections 3035, reflections with I > 2σ(I) 2996, 
reflections used in refinement 3035, parameters refined 203, restraints 1; R(F) [I > 2σ(I) 
reflections] = 0.0286, wR(F2) [all data] = 0.0800 (w = [σ2(Fo2)+ (0.0511P)2+0.0771P]–1, 
where P = (Fo2+2Fc2)/3), goodness of fit 1.034, final ∆max/σ 0.001, ∆ρ (max; min) = 
0.15; –0.10 e Å–3. 
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